Qure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.

Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...

“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead ...

The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for ...

BIOSPAIN 2025 returns to Barcelona, bringing 2,200+ biotech professionals for networking, collaborations, and industry ...